
American Society of Anesthesiologists Consensus-Based
Guidance on Preoperative Management of Patients (Adults and
Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
• GLP-1 agonists are associated with adverse gastrointestinal effects
such as nausea, vomiting and delayed gastric emptying
• Risk of regurgitation and aspiration of gastric contents when GLP-1
not held
• If GLP-1 agonists were not held as advised, proceed with ‘full
stomach’ precautions or
consider evaluating gastric volume by
ultrasound, if possible and if proficient with the technique
. If the
stomach is empty, proceed as usual. If the stomach is full or if gastric
ultrasound inconclusive or not possible, consider delaying the
procedure or treat the patient as ‘full stomach’ and manage
accordingly.
https://www.asahq.org/
Oct 2024